Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-11

Clinical Trial Update: Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update concerns the efficacy of topical pimecrolimus for pityriasis alba in Phase 2/Phase 3 trials, with the trial status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

Sponsor: St Joseph University, Beirut, Lebanon | Conditions: Pityriasis Alba | Phase 2, Phase 3 | Status: UNKNOWN